PKTX Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 bal. 2024 @ 22:08):

Stats
Dzisiejszy wolumen	103 800
Średni wolumen	101 905
Kapitalizacja rynkowa	5.20M
EPS	$0 ( 2024-02-29 )
Następna data zysków	( $0 ) 2024-04-29
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-1.500
ATR14	$0 (0.00%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-29	Smith Clarence Edward	Buy	2 500 000	Common Stock
2024-03-20	Smith Clarence Edward	Buy	666 667	Common Stock
2023-12-26	Smith Clarence Edward	Buy	7 333 334	Common Stock
2023-10-26	Guzzetta Michael Richard	Buy	20 000	Common Stock
2023-08-29	Smith Clarence Edward	Buy	1 500 000	Common Stock

INSIDER POWER
75.34
Last 100 transactions
Buy: 250 709 791 \| Sell: 135 159 880

ProtoKinetix, Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

ProtoKinetix, Finanse

Annual	2023
Przychody:	$0
Zysk brutto:	$-48 259.00 (0.00 %)
EPS:	$-0.00120

FY	2023
Przychody:	$0
Zysk brutto:	$-48 259.00 (0.00 %)
EPS:	$-0.00120

FY	2022
Przychody:	$0
Zysk brutto:	$-58 450.00 (0.00 %)
EPS:	$-0.00620

FY	2021
Przychody:	$0.00
Zysk brutto:	$0.00 (0.00 %)
EPS:	$-0.00794

Financial Reports:

No articles found.

ProtoKinetix,

ProtoKinetix, Incorporated, a research and development stage bio-technology company, focuses on the scientific medical research of anti-freeze glycoproteins (AFGPs) or anti-aging glycoproteins (AAGPs). The company's AFGPs have commercial applications primarily in health care solutions. It develops AAGP to treat dry-eye diseases. It has a collaboration research agreement with the University of British Columbia. The company was formerly known as RJV Network, Inc. and changed its name to ProtoKinetix, Incorporated in July 2003. ProtoKinetix, Incorporated was incorporated in 1999 and is based in Marietta, Ohio.

Aktualne aktualizacje dla ProtoKinetix, [PKTX]

Upcoming Earnings Alert